← Back to search results

OpenFind a Tender · UK4

Radiopharmacy Managed Services

Buyer: Guy's and St Thomas' NHS Foundation Trust →

View official notice ↗Official source

BuyerGuy's and St Thomas' NHS Foundation Trust
StatusOpen
Deadline29 Sept 2026
Value£85,000,000
Published1 Sept 2026

What is being bought

Guy's and St Thoma's NHS Foundation Trust (Contracting Authority) is undertaking this procurement to appoint a Service Provider to enter into an MSA for the provision of Radiopharmacy manufacturing services, delivered through a Hub and Spoke operating model. The Trust’s existing Radiopharmacy Unit, located at Guy’s Hospital (the “Spoke”), provides highly specialised diagnostic, therapeutic and research support to Nuclear Medicine and other clinical services within the GSTT, Royal Brompton and Harefield Hospitals. Radiopharmacy services are integral to a wide range of patient pathways, including diagnostic imaging, cancer diagnosis and treatment, clinical trials and research activity. Demand for radiopharmaceuticals is expected to continue to increase in line with advances in imaging, personalised medicine and oncology pathways. The Contracting Authority’s existing facilities are constrained by physical space, ageing infrastructure and regulatory limitations, which restrict capacity and prevent expansion. The Contracting Authority has therefore determined that an MSA represents the most appropriate mechanism to deliver a new, off site, GMP compliant Radiopharmacy Hub, while retaining a reduced on site Spoke function during the initial phase of service delivery. This approach will enable increased production capacity, improved resilience of supply, enhanced regulatory compliance and long-term sustainability. The Trust intends to implement the Hub and Spoke model through a phased delivery approach. Upon contract award the appointed Service Provider will be responsible for the design and fit-out of the Hub during the first year of the MSA/Contract. During the second year, the Service Provider shall obtain all relevant regulatory licenses with the commencement of services initiating Phase 1 of the Hub starting in the third year. During this phase, the existing Spoke at Guy’s Hospital will continue to provide defined on site radiopharmacy functions to support clinical continuity, resilience and safe transition to the new operating model. These timings are estimates and Tenderers are required to provide a detailed mobilisation as part of their response to Questionnaire 3: Technical and Social Value Questionnaire). At the sole discretion of the Contracting Authority, Phase 2 may be initiated, to transfer additional manufacturing activities from the Spoke to the Hub once the Hub is fully operational, stable and licensed. Phase 2 is not guaranteed and will only be implemented following an initial period from service commencement. Any decision to proceed with Phase 2 will be subject to performance, regulatory and operational readiness criteria as set out in Document 2: Managed Service Agreement). Further detail on the phasing of Services and associated TUPE arrangements is provided in Section 6.6 and the Document 2: Managed Service Agreement). The MSA and procurement documentation have been structured to accommodate this potential future phase in a transparent and compliant manner. This ITT therefore seeks Tenders from suitably qualified and experienced organisations capable of designing, establishing, licensing and operating the Radiopharmacy Hub and working in partnership with the Contracting Authority over the life of the Contract. The scope of Services, phased delivery arrangements and contractual requirements are set out within the ITT Pack, including Document 2: Managed Service Agreement (MSA).

Delivery location

UKI, GB · UKI4, GB

Categories

Medical equipments, pharmaceuticals and personal care products 33000000Radiotherapy devices and supplies 33151000Radiotherapy supplies 33151400Medical preparations excluding dental consumables 33697000Medical specialist services 85121200Services provided by medical laboratories 85145000Pharmacy services 85149000

Lot details

Lot 1

No lot description published.

Statusactive
Value£85,000,000
Contract periodFrom 1 Jul 2027 to 30 Jun 2039

Award criteria
Commercial (30%)
Technical (60%)
Social Vaue (10%)

What is included

ItemCategoryQuantity
1Pharmacy services, Medical specialist services, Services provided by medical laboratories, Medical preparations excluding dental consumables, Medical equipments, pharmaceuticals and personal care products, Radiotherapy devices and supplies, Radiotherapy suppliesNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Medical equipments, pharmaceuticals and personal care products (33000000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 332,0062 median · 94.8 average (715 of 2,006 with a bid count)6.2 average (830 of 2,006 with named award suppliers)Not published
Same buyer6Not publishedNot publishedNot published
Delivery region: UKI542 median · 11.9 average (10 of 54 with a bid count)4.5 average (11 of 54 with named award suppliers)Not published
Similar published value (0.5×–2×)8494 median · 136.3 average (3 of 84 with a bid count)28.7 average (3 of 84 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyallowed
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetValue not published
No-engagement rationalePre-market engagement was undertaken under the PCR2015 regime.
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-06ef52
Latest release ID082551-2026
Latest release timestampTue Sep 01 2026 10:27:33 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLhttps://www.find-tender.service.gov.uk/Notice/082551-2026
Tender statusactive
Procurement methodopen
Procurement method detailsCompetitive flexible procedure
Main procurement categoryservices
Above thresholdYes
Legal basis2023/54
Tender period: startNot published
Tender period: end2026-09-29T12:00:00+01:00
Expression of interest deadlineNot published
Enquiry deadline2026-09-29T12:00:00+01:00
Award period: startNot published
Award period: end2027-06-30T23:59:59+01:00
Submission method detailsThe Contracting Authority is utilising an electronic Tendering system (“E-Tendering Portal”) to manage this procurement and communicate with Tenderers. Accordingly, there will be no hard copy documents issued to Tenderers and all communications with the Contracting Authority, including the submission of Tender responses will be conducted solely via the following link: https://health-family.force.com/s/Welcome User Guide: https://services.atamis.co.uk/docs/Supplier_User_Guide.pdf Unless stated otherwise in these Instructions or in writing from the Contracting Authority, all communications from Tenderers (including their sub-contractors, consortium members, consultants and advisers) during the period of this procurement exercise must be directed via the messaging service on the E-Tendering Portal.
Submission languagesen
Electronic catalogue policyNot published
Total tender value£85,000,000
Tender lots in source1
Tender items in source1
Tender documents in source2
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
1 Sept 2026tender082551-2026

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "082551-2026",
  "tag": [
    "tender"
  ],
  "date": "2026-09-01T11:27:33+01:00",
  "ocid": "ocds-h6vhtk-06ef52",
  "buyer": {
    "id": "GB-PPON-PDZC-6438-DGPX",
    "name": "Guy's and St Thomas' NHS Foundation Trust"
  },
  "tender": {
    "id": "5114-19",
    "lots": [
      {
        "id": "1",
        "value": {
          "amount": 85000000,
          "currency": "GBP",
          "amountGross": 102000000
        },
        "status": "active",
        "renewal": {
          "description": "Up to 60 month extension"
        },
        "hasRenewal": true,
        "description": null,
        "awardCriteria": {
          "criteria": [
            {
              "name": "Commercial",
              "type": "cost",
              "numbers": [
                {
                  "number": 30,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "Technical",
              "type": "quality",
              "numbers": [
                {
                  "number": 60,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "Social Vaue",
              "type": "quality",
              "numbers": [
                {
                  "number": 10,
                  "weight": "percentageExact"
                }
              ]
            }
          ]
        },
        "contractPeriod": {
          "endDate": "2039-06-30T23:59:59+01:00",
          "startDate": "2027-07-01T00:00:00+01:00",
          "maxExtentDate": "2044-06-30T23:59:59+01:00"
        },
        "selectionCriteria": {
          "criteria": [
            {
              "type": "economic",
              "description": "Please see tender documents."
            },
            {
              "type": "technical",
              "description": "Please see tender documents."
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKI",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKI4",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85149000",
            "scheme": "CPV",
            "description": "Pharmacy services"
          },
          {
            "id": "85121200",
            "scheme": "CPV",
            "description": "Medical specialist services"
          },
          {
            "id": "85145000",
            "scheme": "CPV",
            "description": "Services provided by medical laboratories"
          },
          {
            "id": "33697000",
            "scheme": "CPV",
            "description": "Medical preparations excluding dental consumables"
          },
          {
            "id": "33000000",
            "scheme": "CPV",
            "description": "Medical equipments, pharmaceuticals and personal care products"
          },
          {
            "id": "33151000",
            "scheme": "CPV",
            "description": "Radiotherapy devices and supplies"
          },
          {
            "id": "33151400",
            "scheme": "CPV",
            "description": "Radiotherapy supplies"
          }
        ]
      }
    ],
    "title": "Radiopharmacy Managed Services",
    "value": {
      "amount": 85000000,
      "currency": "GBP",
      "amountGross": 102000000
    },
    "status": "active",
    "documents": [
      {
        "id": "conflictOfInterest",
        "documentType": "conflictOfInterest"
      },
      {
        "id": "082551-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/082551-2026",
        "format": "text/html",
        "noticeType": "UK4",
        "description": "Tender notice on Find a Tender",
        "documentType": "tenderNotice",
        "datePublished": "2026-09-01T11:27:33+01:00"
      }
    ],
    "procedure": {
      "features": "Procurement Specific Questionnaire (Stage 1)\nAssessment of Initial Tenders (Stage 2) \nNegotiations (Stage 3). \nBAFO Tenders (Stage 4)"
    },
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "awardPeriod": {
      "endDate": "2027-06-30T23:59:59+01:00"
    },
    "description": "Guy's and St Thoma's NHS Foundation Trust  (Contracting Authority) is undertaking this procurement to appoint a Service Provider to enter into an MSA for the provision of Radiopharmacy manufacturing services, delivered through a Hub and Spoke operating model. \nThe Trust’s existing Radiopharmacy Unit, located at Guy’s Hospital (the “Spoke”), provides highly specialised diagnostic, therapeutic and research support to Nuclear Medicine and other clinical services within the GSTT, Royal Brompton and Harefield Hospitals. Radiopharmacy services are integral to a wide range of patient pathways, including diagnostic imaging, cancer diagnosis and treatment, clinical trials and research activity. Demand for radiopharmaceuticals is expected to continue to increase in line with advances in imaging, personalised medicine and oncology pathways.\nThe Contracting Authority’s existing facilities are constrained by physical space, ageing infrastructure and regulatory limitations, which restrict capacity and prevent expansion. \nThe Contracting Authority has therefore determined that an MSA represents the most appropriate mechanism to deliver a new, off site, GMP compliant Radiopharmacy Hub, while retaining a reduced on site Spoke function during the initial phase of service delivery. This approach will enable increased production capacity, improved resilience of supply, enhanced regulatory compliance and long-term sustainability. \nThe Trust intends to implement the Hub and Spoke model through a phased delivery approach. Upon contract award the appointed Service Provider will be responsible for the design and fit-out of the Hub during the first year of the MSA/Contract. During the second year, the Service Provider shall obtain all relevant regulatory licenses with the commencement of services initiating Phase 1 of the Hub starting in the third year. During this phase, the existing Spoke at Guy’s Hospital will continue to provide defined on site radiopharmacy functions to support clinical continuity, resilience and safe transition to the new operating model. These timings are estimates and Tenderers are required to provide a detailed mobilisation as part of their response to Questionnaire 3: Technical and Social Value Questionnaire).\nAt the sole discretion of the Contracting Authority, Phase 2 may be initiated, to transfer additional manufacturing activities from the Spoke to the Hub once the Hub is fully operational, stable and licensed. Phase 2 is not guaranteed and will only be implemented following an initial period from service commencement. Any decision to proceed with Phase 2 will be subject to performance, regulatory and operational readiness criteria as set out in Document 2: Managed Service Agreement). Further detail on the phasing of Services and associated TUPE arrangements is provided in Section 6.6  and the Document 2: Managed Service Agreement). The MSA and procurement documentation have been structured to accommodate this potential future phase in a transparent and compliant manner.\nThis ITT therefore seeks Tenders from suitably qualified and experienced organisations capable of designing, establishing, licensing and operating the Radiopharmacy Hub and working in partnership with the Contracting Authority over the life of the Contract. The scope of Services, phased delivery arrangements and contractual requirements are set out within the ITT Pack, including Document 2: Managed Service Agreement (MSA).",
    "tenderPeriod": {
      "endDate": "2026-09-29T12:00:00+01:00"
    },
    "contractTerms": {
      "financialTerms": "Please see tender documents."
    },
    "enquiryPeriod": {
      "endDate": "2026-09-29T12:00:00+01:00"
    },
    "aboveThreshold": true,
    "submissionTerms": {
      "languages": [
        "en"
      ],
      "electronicSubmissionPolicy": "allowed"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "services",
    "submissionMethodDetails": "The Contracting Authority is utilising an electronic Tendering system (“E-Tendering Portal”) to manage this procurement and communicate with Tenderers. Accordingly, there will be no hard copy documents issued to Tenderers and all communications with the Contracting Authority, including the submission of Tender responses will be conducted solely via the following link: \nhttps://health-family.force.com/s/Welcome \nUser Guide: \nhttps://services.atamis.co.uk/docs/Supplier_User_Guide.pdf  \nUnless stated otherwise in these Instructions or in writing from the Contracting Authority, all communications from Tenderers (including their sub-contractors, consortium members, consultants and advisers) during the period of this procurement exercise must be directed via the messaging service on the E-Tendering Portal.",
    "procurementMethodDetails": "Competitive flexible procedure"
  },
  "buyerID": [],
  "parties": [
    {
      "id": "GB-PPON-PDZC-6438-DGPX",
      "name": "Guy's and St Thomas' NHS Foundation Trust",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI44",
        "country": "GB",
        "locality": "London",
        "postalCode": "SE1 9RT",
        "countryName": "United Kingdom",
        "streetAddress": "Great Maze Pond"
      },
      "details": {
        "url": "https://www.guysandstthomas.nhs.uk",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PDZC-6438-DGPX",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Bill Martin",
        "email": "helpdesk@smarttogetherlondon.nhs.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "noEngagementNoticeRationale": "Pre-market engagement was undertaken under the PCR2015 regime."
  },
  "initiationType": "tender"
}
Complete JSON history (1 releases)
1 Sept 2026 · 082551-2026 · tender
{
  "id": "082551-2026",
  "tag": [
    "tender"
  ],
  "date": "2026-09-01T11:27:33+01:00",
  "ocid": "ocds-h6vhtk-06ef52",
  "buyer": {
    "id": "GB-PPON-PDZC-6438-DGPX",
    "name": "Guy's and St Thomas' NHS Foundation Trust"
  },
  "tender": {
    "id": "5114-19",
    "lots": [
      {
        "id": "1",
        "value": {
          "amount": 85000000,
          "currency": "GBP",
          "amountGross": 102000000
        },
        "status": "active",
        "renewal": {
          "description": "Up to 60 month extension"
        },
        "hasRenewal": true,
        "description": null,
        "awardCriteria": {
          "criteria": [
            {
              "name": "Commercial",
              "type": "cost",
              "numbers": [
                {
                  "number": 30,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "Technical",
              "type": "quality",
              "numbers": [
                {
                  "number": 60,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "Social Vaue",
              "type": "quality",
              "numbers": [
                {
                  "number": 10,
                  "weight": "percentageExact"
                }
              ]
            }
          ]
        },
        "contractPeriod": {
          "endDate": "2039-06-30T23:59:59+01:00",
          "startDate": "2027-07-01T00:00:00+01:00",
          "maxExtentDate": "2044-06-30T23:59:59+01:00"
        },
        "selectionCriteria": {
          "criteria": [
            {
              "type": "economic",
              "description": "Please see tender documents."
            },
            {
              "type": "technical",
              "description": "Please see tender documents."
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKI",
            "country": "GB",
            "countryName": "United Kingdom"
          },
          {
            "region": "UKI4",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85149000",
            "scheme": "CPV",
            "description": "Pharmacy services"
          },
          {
            "id": "85121200",
            "scheme": "CPV",
            "description": "Medical specialist services"
          },
          {
            "id": "85145000",
            "scheme": "CPV",
            "description": "Services provided by medical laboratories"
          },
          {
            "id": "33697000",
            "scheme": "CPV",
            "description": "Medical preparations excluding dental consumables"
          },
          {
            "id": "33000000",
            "scheme": "CPV",
            "description": "Medical equipments, pharmaceuticals and personal care products"
          },
          {
            "id": "33151000",
            "scheme": "CPV",
            "description": "Radiotherapy devices and supplies"
          },
          {
            "id": "33151400",
            "scheme": "CPV",
            "description": "Radiotherapy supplies"
          }
        ]
      }
    ],
    "title": "Radiopharmacy Managed Services",
    "value": {
      "amount": 85000000,
      "currency": "GBP",
      "amountGross": 102000000
    },
    "status": "active",
    "documents": [
      {
        "id": "conflictOfInterest",
        "documentType": "conflictOfInterest"
      },
      {
        "id": "082551-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/082551-2026",
        "format": "text/html",
        "noticeType": "UK4",
        "description": "Tender notice on Find a Tender",
        "documentType": "tenderNotice",
        "datePublished": "2026-09-01T11:27:33+01:00"
      }
    ],
    "procedure": {
      "features": "Procurement Specific Questionnaire (Stage 1)\nAssessment of Initial Tenders (Stage 2) \nNegotiations (Stage 3). \nBAFO Tenders (Stage 4)"
    },
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "awardPeriod": {
      "endDate": "2027-06-30T23:59:59+01:00"
    },
    "description": "Guy's and St Thoma's NHS Foundation Trust  (Contracting Authority) is undertaking this procurement to appoint a Service Provider to enter into an MSA for the provision of Radiopharmacy manufacturing services, delivered through a Hub and Spoke operating model. \nThe Trust’s existing Radiopharmacy Unit, located at Guy’s Hospital (the “Spoke”), provides highly specialised diagnostic, therapeutic and research support to Nuclear Medicine and other clinical services within the GSTT, Royal Brompton and Harefield Hospitals. Radiopharmacy services are integral to a wide range of patient pathways, including diagnostic imaging, cancer diagnosis and treatment, clinical trials and research activity. Demand for radiopharmaceuticals is expected to continue to increase in line with advances in imaging, personalised medicine and oncology pathways.\nThe Contracting Authority’s existing facilities are constrained by physical space, ageing infrastructure and regulatory limitations, which restrict capacity and prevent expansion. \nThe Contracting Authority has therefore determined that an MSA represents the most appropriate mechanism to deliver a new, off site, GMP compliant Radiopharmacy Hub, while retaining a reduced on site Spoke function during the initial phase of service delivery. This approach will enable increased production capacity, improved resilience of supply, enhanced regulatory compliance and long-term sustainability. \nThe Trust intends to implement the Hub and Spoke model through a phased delivery approach. Upon contract award the appointed Service Provider will be responsible for the design and fit-out of the Hub during the first year of the MSA/Contract. During the second year, the Service Provider shall obtain all relevant regulatory licenses with the commencement of services initiating Phase 1 of the Hub starting in the third year. During this phase, the existing Spoke at Guy’s Hospital will continue to provide defined on site radiopharmacy functions to support clinical continuity, resilience and safe transition to the new operating model. These timings are estimates and Tenderers are required to provide a detailed mobilisation as part of their response to Questionnaire 3: Technical and Social Value Questionnaire).\nAt the sole discretion of the Contracting Authority, Phase 2 may be initiated, to transfer additional manufacturing activities from the Spoke to the Hub once the Hub is fully operational, stable and licensed. Phase 2 is not guaranteed and will only be implemented following an initial period from service commencement. Any decision to proceed with Phase 2 will be subject to performance, regulatory and operational readiness criteria as set out in Document 2: Managed Service Agreement). Further detail on the phasing of Services and associated TUPE arrangements is provided in Section 6.6  and the Document 2: Managed Service Agreement). The MSA and procurement documentation have been structured to accommodate this potential future phase in a transparent and compliant manner.\nThis ITT therefore seeks Tenders from suitably qualified and experienced organisations capable of designing, establishing, licensing and operating the Radiopharmacy Hub and working in partnership with the Contracting Authority over the life of the Contract. The scope of Services, phased delivery arrangements and contractual requirements are set out within the ITT Pack, including Document 2: Managed Service Agreement (MSA).",
    "tenderPeriod": {
      "endDate": "2026-09-29T12:00:00+01:00"
    },
    "contractTerms": {
      "financialTerms": "Please see tender documents."
    },
    "enquiryPeriod": {
      "endDate": "2026-09-29T12:00:00+01:00"
    },
    "aboveThreshold": true,
    "submissionTerms": {
      "languages": [
        "en"
      ],
      "electronicSubmissionPolicy": "allowed"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "services",
    "submissionMethodDetails": "The Contracting Authority is utilising an electronic Tendering system (“E-Tendering Portal”) to manage this procurement and communicate with Tenderers. Accordingly, there will be no hard copy documents issued to Tenderers and all communications with the Contracting Authority, including the submission of Tender responses will be conducted solely via the following link: \nhttps://health-family.force.com/s/Welcome \nUser Guide: \nhttps://services.atamis.co.uk/docs/Supplier_User_Guide.pdf  \nUnless stated otherwise in these Instructions or in writing from the Contracting Authority, all communications from Tenderers (including their sub-contractors, consortium members, consultants and advisers) during the period of this procurement exercise must be directed via the messaging service on the E-Tendering Portal.",
    "procurementMethodDetails": "Competitive flexible procedure"
  },
  "buyerID": [],
  "parties": [
    {
      "id": "GB-PPON-PDZC-6438-DGPX",
      "name": "Guy's and St Thomas' NHS Foundation Trust",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI44",
        "country": "GB",
        "locality": "London",
        "postalCode": "SE1 9RT",
        "countryName": "United Kingdom",
        "streetAddress": "Great Maze Pond"
      },
      "details": {
        "url": "https://www.guysandstthomas.nhs.uk",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PDZC-6438-DGPX",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Bill Martin",
        "email": "helpdesk@smarttogetherlondon.nhs.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "noEngagementNoticeRationale": "Pre-market engagement was undertaken under the PCR2015 regime."
  },
  "initiationType": "tender"
}